期刊
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
卷 45, 期 3, 页码 573-576出版社
WILEY-HINDAWI
DOI: 10.1111/jcpt.13089
关键词
drug-related side effects and adverse reactions; leishmaniasis; meglumine antimoniate; pharmacovigilance
What is known and objectives Adverse drug reactions (ADR) related to the treatment of visceral leishmaniasis (VL) can cause severe clinical complications. We report a case series of ADR in hospitalized VL patients on meglumine antimoniate (MA). Case description Seven cases of patients taking MA had at least one objective evidence for suspected ADR, including electrocardiographic, laboratory or clinical alteration. What is new and conclusion Meglumine antimoniate is highly toxic. Adherence to treatment guidelines is important. Pharmacists working in multidisciplinary teams may contribute to early detection and management of MA therapy-related ADR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据